Literature DB >> 27106476

Frequently Increased but Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus.

Leilei Zhou1, Tianyi Cao1, Yufeng Wang1, Hui Yao1, Guanhuan Du1, Guangjie Chen2, Xiaoyin Niu2, Guoyao Tang3.   

Abstract

Oral lichen planus (OLP) is a T cell-mediated chronic inflammatory mucosal disease, and CD4(+)CD25(+) regulatory T cells (Tregs) are considered involved in the pathogenesis of OLP. In this study, to investigate whether there are intrinsic factors that might cause functional changes in Tregs in this disease, we evaluated the frequency of Tregs in peripheral blood and oral lesions and the expression levels of function-related transcription factors, forkhead/winged-helix transcription factor box P3 (FOXP3), transforming growth factor β (TGF-β), interleukin 10 (IL-10), and TGF-β receptors (TβRI and TβRII) mRNAs in Tregs of patients with oral lichen planus (OLP). We also investigated the frequency of pro-inflammatory cytokines (IFN-γ and IL-17A) producing Foxp3(+) regulatory cells. Increased proportions of Tregs were found in OLP patients. The expression of FOXP3 on mRNA and protein level was elevated in the Tregs of OLP. The expression of TGF-β was lower both on the mRNA and serum level, whereas the expression of IL-10 showed no significant difference between the OLP patients and normal controls. The percentages of CD4(+)FOXP3(+)IL-17(+) T cells were significantly higher than that of normal controls, whereas the percentages of CD4(+)FOXP3(+)IFN-γ(+) T cells did not differ significantly. Furthermore, impaired suppressive function of CD4(+)CD25(+) T cells was demonstrated in OLP patients by in vitro proliferation assay. These data indicate that Tregs in OLP are frequently expanded but functionally deficient. This could explain, at least in part, why the increased Tregs in OLP fail to control the pathogenesis and development of this autoimmune disease.

Entities:  

Keywords:  FOXP3; IL-10; IL-17A; TGF-β; oral lichen planus; regulatory T cells

Mesh:

Substances:

Year:  2016        PMID: 27106476     DOI: 10.1007/s10753-016-0356-9

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  42 in total

1.  Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation.

Authors:  Hideaki Sugiyama; Rolland Gyulai; Eiko Toichi; Edina Garaczi; Shinji Shimada; Seth R Stevens; Thomas S McCormick; Kevin D Cooper
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

2.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

Review 3.  Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases.

Authors:  Jane Hoyt Buckner
Journal:  Nat Rev Immunol       Date:  2010-12       Impact factor: 53.106

4.  Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta.

Authors:  Anthony Joetham; Katsuyuki Takeda; Katsuyuki Takada; Christian Taube; Nobuaki Miyahara; Shigeki Matsubara; Satoko Matsubara; Toshiyuki Koya; Yeong-Ho Rha; Azzeddine Dakhama; Erwin W Gelfand
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

6.  Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo.

Authors:  Mei-Ling Chen; Mikaël J Pittet; Leonid Gorelik; Richard A Flavell; Ralph Weissleder; Harald von Boehmer; Khashayarsha Khazaie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-27       Impact factor: 11.205

7.  Expression of Foxp3 and interleukin-17 in lichen planus lesions with emphasis on difference in oral and cutaneous variants.

Authors:  Zhengyu Shen; Xing Gao; Liwei Ma; Zengtong Zhou; Xuemin Shen; Wei Liu
Journal:  Arch Dermatol Res       Date:  2013-11-29       Impact factor: 3.017

8.  T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation.

Authors:  Ming O Li; Yisong Y Wan; Richard A Flavell
Journal:  Immunity       Date:  2007-05-03       Impact factor: 31.745

9.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

Authors:  Weihong Liu; Amy L Putnam; Zhou Xu-Yu; Gregory L Szot; Michael R Lee; Shirley Zhu; Peter A Gottlieb; Philipp Kapranov; Thomas R Gingeras; Barbara Fazekas de St Groth; Carol Clayberger; David M Soper; Steven F Ziegler; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

10.  Oral lichen planus versus epithelial dysplasia: difficulties in diagnosis.

Authors:  Fernando Augusto Cervantes Garcia de Sousa; Thaís Cachuté Paradella; Adriana Aigotti Haberbeck Brandão; Luiz Eduardo Blumer Rosa
Journal:  Braz J Otorhinolaryngol       Date:  2009 Sep-Oct
View more
  6 in total

1.  [Postoperative changes of Th17/Treg balance in patients with intracranial aneurysm rupture].

Authors:  Zai Liang; Hong-Jian Jian; Qian-Yi Lin; Sai-Hua Luo; Xiao-Peng Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-04-20

Review 2.  Artemisinin and its derivatives: a potential therapeutic approach for oral lichen planus.

Authors:  Rui-Jie Ma; Ming-Jing He; Ya-Qin Tan; Gang Zhou
Journal:  Inflamm Res       Date:  2019-02-01       Impact factor: 4.575

3.  Immunopathogenesis of canine chronic ulcerative stomatitis.

Authors:  J G Anderson; A Kol; P Bizikova; B P Stapelton; K Ford; A Villarreal; R J Jimenez; D Vasilatis; B G Murphy
Journal:  PLoS One       Date:  2020-01-10       Impact factor: 3.240

4.  FoxP3+CD4+, IFN-γ+CD4+, and IFN-γ+CD8+ cell levels in erosive and non-erosive types of oral lichen planus patients.

Authors:  Andy Sun; Yu-Hsueh Wu; Julia Yu-Fong Chang; Yi-Ping Wang; Chun-Pin Chiang; Jean-San Chia
Journal:  J Dent Sci       Date:  2021-01-27       Impact factor: 2.080

5.  Deregulation of circ_003912 contributes to pathogenesis of erosive oral lichen planus by via sponging microRNA-123, -647 and -31 and upregulating FOXP3.

Authors:  Zhen Huang; Fen Liu; Wenjuan Wang; Shaobo Ouyang; Ting Sang; Zikun Huang; Lan Liao; Jun Wu
Journal:  Mol Med       Date:  2021-10-20       Impact factor: 6.354

6.  Increased Serum Level and High Tissue Immunoexpression of Interleukin 17 in Cutaneous Lichen Planus: A Novel Therapeutic Target for Recalcitrant Cases?

Authors:  Magdalena Żychowska; Aleksandra Batycka-Baran; Wojciech Baran
Journal:  Dis Markers       Date:  2020-07-24       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.